Antitrust

• A pharmaceutical company, acting as a claimant in an abuse of dominance case before the European Commission (exclusionary practices and the use of divisional patents). 
• A German manufacturer of synthetic outdoor sports and leisure surfaces, in an ongoing investigation before the European Commission concerning alleged anticompetitive practices in the artificial turf recycling sector.
• A French manufacturer of household appliances, in a cartel investigation conducted by the French Competition Authority.
• A former parent company of an entity in the concrete sector, in a cartel investigation before the French Competition Authority.

Merger Control

• Various private equity funds, in coordinating multijurisdictional merger control and FDI filings. 
• A cryptocurrency company, in several cross-border acquisition transactions including preliminary merger control assessment and merger control filings.
• A U.S. defense and aerospace manufacturer, in several cross-border transactions.
• A subsidiary of a French nuclear company, in the creation of a joint venture in the pharmaceutical sector.
• A U.S. agrochemicals company, in the creation of a joint venture in the biofuels sector.

Foreign Subsidies Regulation

• A U.S. provider of mission-critical communication and security technologies, on implementing internal FSR compliance frameworks, including mapping of foreign financial contributions, developing an internal reporting process, integrating FSR requirements into M&A due diligence and providing training sessions. 
• A Japanese medical imaging company, in preparing and submitting several notifications before the European Commission in connection with public procurement procedures in the healthcare sector, including advice on reporting third-country financial contributions and coordination with internal legal and financial teams.

Matters may have been completed before joining Paul Hastings.